Sponsored

Reimagining Care Beyond HIV Viral Suppression: What’s Next?

September 30th 2025

The Dawn of a New Era: Metagenomic Diagnostics for Central Nervous System Infections

August 25th 2025

IDWeek 2024 Review: Shionogi's Antibiotic for Use in Adults with Certain Gram-negative Bacterial Infections

April 24th 2025

Once-Weekly Echinocandin Could Facilitate Continuity of Echinocandin Treatment and Outpatient Administration

October 10th 2023

Conversation, compassion and community: Planning for healthy futures with HIV

June 9th 2021

The Importance of Understanding the CDC Hepatitis A Vaccine Guidelines

ByMichelle Goveia, MD, MPH, Global Medical Director at Merck

August 28th 2020

Acute Bacterial Skin and Skin Structure Infections: A Modernized Approach

ByKerry Cleveland, MD, FACP, FIDSA, FSHEA

August 8th 2019

The emergence of hospital- and community-based MRSA and other resistant gram-positive pathogens have made ABSSSI a critical public health challenge.

Antibiotic Resistance: Challenges and Opportunities for Treating Serious Bacterial Skin Infections

ByEvan Loh, MD, Chief Executive Officer, Paratek Pharmaceuticals

July 11th 2019

As current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.

Reimagining Care Beyond HIV Viral Suppression: What’s Next?

The Dawn of a New Era: Metagenomic Diagnostics for Central Nervous System Infections

IDWeek 2024 Review: Shionogi's Antibiotic for Use in Adults with Certain Gram-negative Bacterial Infections

Once-Weekly Echinocandin Could Facilitate Continuity of Echinocandin Treatment and Outpatient Administration

Conversation, compassion and community: Planning for healthy futures with HIV

The Importance of Understanding the CDC Hepatitis A Vaccine Guidelines

Acute Bacterial Skin and Skin Structure Infections: A Modernized Approach

Antibiotic Resistance: Challenges and Opportunities for Treating Serious Bacterial Skin Infections

Trending on Contagion Live

Public Health Wake-Up Call: Will the US Lose Measles Elimination Status?

Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Meets Primary Endpoint in Phase 3 Study

Recent Florida Cases of Chikungunya Linked to Cuba Travelers, Reminder Vector-Borne Illness is Still Circulating

Zoliflodacin Emerges as a First-in-Class Oral Option Against Drug-Resistant Gonorrhea

Caring Holistically: NYU’s Approach to Pediatric Infectious Disease